NIH's Role In Sustaining the U.S. Economy 2021 Update Now Available here
UMR Urges House and Senate Leaders to Include NIH Funding in COVID Relief Package read here
UMR releases new fact sheets on COVID-19 and biomedical research. Read here
See how UMR members are aiding in the fight against the coronavirus here
A new episode of the Amazing Things Podcast is now available! Check it out here.

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Ensuring global vaccine equity requires eliminating trade and regulatory barriers

Since the emergency use authorization of the first COVID-19 vaccine in December 2020, health experts have underscored that in order to combat the pandemic, vaccines must be widely available, accessible and reach people worldwide. To help make this a reality, the biopharmaceutical industry, governments and other stakeholders have been working tirelessly to scale up manufacturing and production and establish mechanisms for vaccine dose sharing to support equitable access globally. Today, COVID-19 vaccines have been administered across 180 countries, and production is expected to climb to 11 billion vaccine doses by the end of 2021.